Abstract
The production of counterfeit drugs is a broad and under reported problem particularly affecting poorer countries. It is an important cause of unnecessary mortality and morbidity, and loss of public confidence in medicines and health structures. Empirical observations show that there may be more counterfeit than genuine drugs in circulation. This article discusses the prevalence of counterfeit drugs in Nigeria. It highlights factors contributing to the preponderance of counterfeit pharmaceuticals and discusses strategies that may influence policy to combat the menace of counterfeit drugs. Major factors contributing to the prevalence of counterfeit drugs in Nigeria include ineffective enforcement of existing laws, non- professionals in drug business, loose control systems, high cost of genuine drugs, greed, ignorance, corruption, illegal drug importation, chaotic drug distribution network, demand exceeding supply amongst many others. Counterfeit drugs pose great threats to the attainment of the millennium development goals 4, 5 and 6 which hopes for a reduction in infant mortality, improved maternal health and combating human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), malaria and other diseases. Due to the complexity of the counterfeit drug problem, no single technique can eliminate the public health threat posed by counterfeit pharmaceuticals. A multi-disciplinary and cross-functional approach will help combat the prevalence of counterfeit drugs in Nigeria. Key words: Counterfeit drugs, public health, Nigeria.
Highlights
The deleterious implications of counterfeit drugs is understood to be a central challenge to the integrity of public health systems around the globe, as well as a direct threat to individual health and welfare (Finlay, 2011)
It highlights factors contributing to the preponderance of counterfeit pharmaceuticals and discusses strategies that may influence policy to combat the menace of counterfeit drugs
Due to the complexity of the counterfeit drug problem, no single technique can eliminate the public health threat posed by counterfeit pharmaceuticals
Summary
The deleterious implications of counterfeit drugs is understood to be a central challenge to the integrity of public health systems around the globe, as well as a direct threat to individual health and welfare (Finlay, 2011). The prevalence of counterfeit drugs appear to be rising and has not been countered by close cooperation between pharmaceutical companies, government, and international organisations concerned with trade, health, customs and excise, and counterfeiting. The issue of drug counterfeiting has been reported mostly in local newspapers (Kelesidis et al, 2007). There is little published medical research assessing their prevalence, public health impact, or probable countermeasures (Newton et al, 2002). Few studies have reported a high incidence on the availability of counterfeit drugs, majority of these reports do not contain quantitative data supporting these claims
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
